Performance guarantees for individualized treatment rules

From MaRDI portal
Publication:548554


DOI10.1214/10-AOS864zbMath1216.62178arXiv1105.3369WikidataQ42748821 ScholiaQ42748821MaRDI QIDQ548554

Min Qian, Susan A. Murphy

Publication date: 29 June 2011

Published in: The Annals of Statistics (Search for Journal in Brave)

Full work available at URL: https://arxiv.org/abs/1105.3369


62H99: Multivariate analysis

62P10: Applications of statistics to biology and medical sciences; meta analysis

92C50: Medical applications (general)

62C99: Statistical decision theory

62N02: Estimation in survival analysis and censored data


Related Items

Unnamed Item, Unnamed Item, Estimating Individualized Treatment Rules Using Outcome Weighted Learning, Functional Feature Construction for Individualized Treatment Regimes, Quantile-Optimal Treatment Regimes, Learning Optimal Personalized Treatment Rules in Consideration of Benefit and Risk: With an Application to Treating Type 2 Diabetes Patients With Insulin Therapies, A Robust Method for Estimating Optimal Treatment Regimes, A Simple Method for Estimating Interactions Between a Treatment and a Large Number of Covariates, Focused information criterion on predictive models in personalized medicine, Greedy outcome weighted tree learning of optimal personalized treatment rules, Estimating treatment effect heterogeneity in randomized program evaluation, Sequential Advantage Selection for Optimal Treatment Regimes, Statistical inference for the mean outcome under a possibly non-unique optimal treatment strategy, Discussion of ``Dynamic treatment regimes: technical challenges and applications, Rejoinder of ``Dynamic treatment regimes: technical challenges and applications, Performance guarantees for individualized treatment rules, D-learning to estimate optimal individual treatment rules, High-dimensional \(A\)-learning for optimal dynamic treatment regimes, High-dimensional inference for personalized treatment decision, Optimal designs for dose-response models with linear effects of covariates, Variable selection for estimating the optimal treatment regimes in the presence of a large number of covariates, The use of covariates and random effects in evaluating predictive biomarkers under a potential outcome framework, Regularized outcome weighted subgroup identification for differential treatment effects, Treatment decisions based on scalar and functional baseline covariates, Using decision lists to construct interpretable and parsimonious treatment regimes, A predictive enrichment procedure to identify potential responders to a new therapy for randomized, comparative controlled clinical studies, Evaluating marker-guided treatment selection strategies, Combining biomarkers to optimize patient treatment recommendations, Towards Min Max Generalization in Reinforcement Learning, Incorporating Patient Preferences into Estimation of Optimal Individualized Treatment Rules, Interpretable Dynamic Treatment Regimes, Identifying optimal biomarker combinations for treatment selection via a robust kernel method



Cites Work